Serveur d'exploration Posturo

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The effect of continuous epidural infusion of ropivacaine (0.1%, 0.2% and 0.3%) on nerve conduction velocity and postural control in volunteers.

Identifieur interne : 001503 ( Main/Exploration ); précédent : 001502; suivant : 001504

The effect of continuous epidural infusion of ropivacaine (0.1%, 0.2% and 0.3%) on nerve conduction velocity and postural control in volunteers.

Auteurs : D. Zaric [Suède] ; P A Nydahl ; S O Adel ; H. Enbom ; M. Magnusson ; L. Philipson ; K. Axelsson

Source :

RBID : pubmed:8721466

Descripteurs français

English descriptors

Abstract

BACKGROUND

Continuous epidural infusions of local anaesthetics have become increasingly popular in postoperative pain treatment, especially as they permit early mobilisation. Ropivacaine is a promising new agent which induces more pronounced sensory than motor blockade. This study was focused on the influence of continuous epidural infusion of ropivacaine on impulse conduction in large nerves (by measurement of F and H latencies), and on the subjects' ability to maintain postural control during mobilisation.

METHODS

Healthy male volunteers received 0.1%, 0.2% or 0.3% ropivacaine, and bupivacaine 0.25% was used as reference. A bolus epidural injection of 10 ml of the drug, at L2/3 level, was followed by continuous infusion at 10 ml/h for 21 h. Motor blockade was assessed by mechanical measurements of force during big toe flexion and by recording of F latency. Sensory blockade was monitored by pin-prick and Thermotest methods, and by H latency recording. The subjects' ability to perform a postural test was evaluated by posturography.

RESULTS

The F and H latencies became prolonged/abolished dose-dependently. With ropivacaine, F latency recovered significantly later than motor function (P = 0.0002), and H latency recovered later than normal pin-prick perception (P = 0.0006). However, the duration of partial blockade of thermoperception was comparable to that of H latency prolongation. Posturographically, the subjects receiving 0.1% ropivacaine differed significantly from all others (P < 0.001) in that they were able to maintain postural control during the infusion. The recovery period after termination of infusion was significantly shorter with ropivacaine than with bupivacaine for all measured variables.

CONCLUSION

Recovery of postural control with 0.2% and 0.3% ropivacaine is significantly faster than with bupivacaine 0.25%. H latency recording allows detection of epidural blockade intensity that does not prevent subjects from performing postural tests.


DOI: 10.1111/j.1399-6576.1996.tb04443.x
PubMed: 8721466


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The effect of continuous epidural infusion of ropivacaine (0.1%, 0.2% and 0.3%) on nerve conduction velocity and postural control in volunteers.</title>
<author>
<name sortKey="Zaric, D" sort="Zaric, D" uniqKey="Zaric D" first="D" last="Zaric">D. Zaric</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Anaesthesiology, Lund University of Hospital, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Anaesthesiology, Lund University of Hospital</wicri:regionArea>
<wicri:noRegion>Lund University of Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nydahl, P A" sort="Nydahl, P A" uniqKey="Nydahl P" first="P A" last="Nydahl">P A Nydahl</name>
</author>
<author>
<name sortKey="Adel, S O" sort="Adel, S O" uniqKey="Adel S" first="S O" last="Adel">S O Adel</name>
</author>
<author>
<name sortKey="Enbom, H" sort="Enbom, H" uniqKey="Enbom H" first="H" last="Enbom">H. Enbom</name>
</author>
<author>
<name sortKey="Magnusson, M" sort="Magnusson, M" uniqKey="Magnusson M" first="M" last="Magnusson">M. Magnusson</name>
</author>
<author>
<name sortKey="Philipson, L" sort="Philipson, L" uniqKey="Philipson L" first="L" last="Philipson">L. Philipson</name>
</author>
<author>
<name sortKey="Axelsson, K" sort="Axelsson, K" uniqKey="Axelsson K" first="K" last="Axelsson">K. Axelsson</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1996">1996</date>
<idno type="RBID">pubmed:8721466</idno>
<idno type="pmid">8721466</idno>
<idno type="doi">10.1111/j.1399-6576.1996.tb04443.x</idno>
<idno type="wicri:Area/Main/Corpus">001519</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001519</idno>
<idno type="wicri:Area/Main/Curation">001519</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001519</idno>
<idno type="wicri:Area/Main/Exploration">001519</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The effect of continuous epidural infusion of ropivacaine (0.1%, 0.2% and 0.3%) on nerve conduction velocity and postural control in volunteers.</title>
<author>
<name sortKey="Zaric, D" sort="Zaric, D" uniqKey="Zaric D" first="D" last="Zaric">D. Zaric</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Anaesthesiology, Lund University of Hospital, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Anaesthesiology, Lund University of Hospital</wicri:regionArea>
<wicri:noRegion>Lund University of Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nydahl, P A" sort="Nydahl, P A" uniqKey="Nydahl P" first="P A" last="Nydahl">P A Nydahl</name>
</author>
<author>
<name sortKey="Adel, S O" sort="Adel, S O" uniqKey="Adel S" first="S O" last="Adel">S O Adel</name>
</author>
<author>
<name sortKey="Enbom, H" sort="Enbom, H" uniqKey="Enbom H" first="H" last="Enbom">H. Enbom</name>
</author>
<author>
<name sortKey="Magnusson, M" sort="Magnusson, M" uniqKey="Magnusson M" first="M" last="Magnusson">M. Magnusson</name>
</author>
<author>
<name sortKey="Philipson, L" sort="Philipson, L" uniqKey="Philipson L" first="L" last="Philipson">L. Philipson</name>
</author>
<author>
<name sortKey="Axelsson, K" sort="Axelsson, K" uniqKey="Axelsson K" first="K" last="Axelsson">K. Axelsson</name>
</author>
</analytic>
<series>
<title level="j">Acta anaesthesiologica Scandinavica</title>
<idno type="ISSN">0001-5172</idno>
<imprint>
<date when="1996" type="published">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult (MeSH)</term>
<term>Amides (administration & dosage)</term>
<term>Amides (pharmacology)</term>
<term>Anesthesia Recovery Period (MeSH)</term>
<term>Anesthesia, Epidural (MeSH)</term>
<term>Anesthetics, Local (administration & dosage)</term>
<term>Anesthetics, Local (pharmacology)</term>
<term>Bupivacaine (administration & dosage)</term>
<term>Bupivacaine (pharmacology)</term>
<term>Dose-Response Relationship, Drug (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Injections, Epidural (MeSH)</term>
<term>Male (MeSH)</term>
<term>Mechanoreceptors (drug effects)</term>
<term>Motor Neurons (drug effects)</term>
<term>Nerve Block (MeSH)</term>
<term>Neural Conduction (drug effects)</term>
<term>Neurons, Afferent (drug effects)</term>
<term>Nociceptors (drug effects)</term>
<term>Posture (MeSH)</term>
<term>Proprioception (drug effects)</term>
<term>Reaction Time (drug effects)</term>
<term>Ropivacaine (MeSH)</term>
<term>Sensation (drug effects)</term>
<term>Thermoreceptors (drug effects)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte (MeSH)</term>
<term>Amides (administration et posologie)</term>
<term>Amides (pharmacologie)</term>
<term>Anesthésie péridurale (MeSH)</term>
<term>Anesthésiques locaux (administration et posologie)</term>
<term>Anesthésiques locaux (pharmacologie)</term>
<term>Bloc nerveux (MeSH)</term>
<term>Bupivacaïne (administration et posologie)</term>
<term>Bupivacaïne (pharmacologie)</term>
<term>Conduction nerveuse (effets des médicaments et des substances chimiques)</term>
<term>Humains (MeSH)</term>
<term>Injections épidurales (MeSH)</term>
<term>Motoneurones (effets des médicaments et des substances chimiques)</term>
<term>Mâle (MeSH)</term>
<term>Mécanorécepteurs (effets des médicaments et des substances chimiques)</term>
<term>Neurones afférents (effets des médicaments et des substances chimiques)</term>
<term>Nocicepteurs (effets des médicaments et des substances chimiques)</term>
<term>Posture (MeSH)</term>
<term>Proprioception (effets des médicaments et des substances chimiques)</term>
<term>Relation dose-effet des médicaments (MeSH)</term>
<term>Ropivacaïne (MeSH)</term>
<term>Réveil anesthésique (MeSH)</term>
<term>Sensation (effets des médicaments et des substances chimiques)</term>
<term>Temps de réaction (effets des médicaments et des substances chimiques)</term>
<term>Thermorécepteurs (effets des médicaments et des substances chimiques)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Amides</term>
<term>Anesthetics, Local</term>
<term>Bupivacaine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Amides</term>
<term>Anesthetics, Local</term>
<term>Bupivacaine</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Amides</term>
<term>Anesthésiques locaux</term>
<term>Bupivacaïne</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Mechanoreceptors</term>
<term>Motor Neurons</term>
<term>Neural Conduction</term>
<term>Neurons, Afferent</term>
<term>Nociceptors</term>
<term>Proprioception</term>
<term>Reaction Time</term>
<term>Sensation</term>
<term>Thermoreceptors</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Conduction nerveuse</term>
<term>Motoneurones</term>
<term>Mécanorécepteurs</term>
<term>Neurones afférents</term>
<term>Nocicepteurs</term>
<term>Proprioception</term>
<term>Sensation</term>
<term>Temps de réaction</term>
<term>Thermorécepteurs</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Amides</term>
<term>Anesthésiques locaux</term>
<term>Bupivacaïne</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Anesthesia Recovery Period</term>
<term>Anesthesia, Epidural</term>
<term>Dose-Response Relationship, Drug</term>
<term>Humans</term>
<term>Injections, Epidural</term>
<term>Male</term>
<term>Nerve Block</term>
<term>Posture</term>
<term>Ropivacaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Anesthésie péridurale</term>
<term>Bloc nerveux</term>
<term>Humains</term>
<term>Injections épidurales</term>
<term>Mâle</term>
<term>Posture</term>
<term>Relation dose-effet des médicaments</term>
<term>Ropivacaïne</term>
<term>Réveil anesthésique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>Continuous epidural infusions of local anaesthetics have become increasingly popular in postoperative pain treatment, especially as they permit early mobilisation. Ropivacaine is a promising new agent which induces more pronounced sensory than motor blockade. This study was focused on the influence of continuous epidural infusion of ropivacaine on impulse conduction in large nerves (by measurement of F and H latencies), and on the subjects' ability to maintain postural control during mobilisation.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>Healthy male volunteers received 0.1%, 0.2% or 0.3% ropivacaine, and bupivacaine 0.25% was used as reference. A bolus epidural injection of 10 ml of the drug, at L2/3 level, was followed by continuous infusion at 10 ml/h for 21 h. Motor blockade was assessed by mechanical measurements of force during big toe flexion and by recording of F latency. Sensory blockade was monitored by pin-prick and Thermotest methods, and by H latency recording. The subjects' ability to perform a postural test was evaluated by posturography.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>The F and H latencies became prolonged/abolished dose-dependently. With ropivacaine, F latency recovered significantly later than motor function (P = 0.0002), and H latency recovered later than normal pin-prick perception (P = 0.0006). However, the duration of partial blockade of thermoperception was comparable to that of H latency prolongation. Posturographically, the subjects receiving 0.1% ropivacaine differed significantly from all others (P < 0.001) in that they were able to maintain postural control during the infusion. The recovery period after termination of infusion was significantly shorter with ropivacaine than with bupivacaine for all measured variables.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSION</b>
</p>
<p>Recovery of postural control with 0.2% and 0.3% ropivacaine is significantly faster than with bupivacaine 0.25%. H latency recording allows detection of epidural blockade intensity that does not prevent subjects from performing postural tests.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">8721466</PMID>
<DateCompleted>
<Year>1996</Year>
<Month>09</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>08</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0001-5172</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>40</Volume>
<Issue>3</Issue>
<PubDate>
<Year>1996</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Acta anaesthesiologica Scandinavica</Title>
<ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation>
</Journal>
<ArticleTitle>The effect of continuous epidural infusion of ropivacaine (0.1%, 0.2% and 0.3%) on nerve conduction velocity and postural control in volunteers.</ArticleTitle>
<Pagination>
<MedlinePgn>342-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Continuous epidural infusions of local anaesthetics have become increasingly popular in postoperative pain treatment, especially as they permit early mobilisation. Ropivacaine is a promising new agent which induces more pronounced sensory than motor blockade. This study was focused on the influence of continuous epidural infusion of ropivacaine on impulse conduction in large nerves (by measurement of F and H latencies), and on the subjects' ability to maintain postural control during mobilisation.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Healthy male volunteers received 0.1%, 0.2% or 0.3% ropivacaine, and bupivacaine 0.25% was used as reference. A bolus epidural injection of 10 ml of the drug, at L2/3 level, was followed by continuous infusion at 10 ml/h for 21 h. Motor blockade was assessed by mechanical measurements of force during big toe flexion and by recording of F latency. Sensory blockade was monitored by pin-prick and Thermotest methods, and by H latency recording. The subjects' ability to perform a postural test was evaluated by posturography.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The F and H latencies became prolonged/abolished dose-dependently. With ropivacaine, F latency recovered significantly later than motor function (P = 0.0002), and H latency recovered later than normal pin-prick perception (P = 0.0006). However, the duration of partial blockade of thermoperception was comparable to that of H latency prolongation. Posturographically, the subjects receiving 0.1% ropivacaine differed significantly from all others (P < 0.001) in that they were able to maintain postural control during the infusion. The recovery period after termination of infusion was significantly shorter with ropivacaine than with bupivacaine for all measured variables.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Recovery of postural control with 0.2% and 0.3% ropivacaine is significantly faster than with bupivacaine 0.25%. H latency recording allows detection of epidural blockade intensity that does not prevent subjects from performing postural tests.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zaric</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology, Lund University of Hospital, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nydahl</LastName>
<ForeName>P A</ForeName>
<Initials>PA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Adel</LastName>
<ForeName>S O</ForeName>
<Initials>SO</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Enbom</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Magnusson</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Philipson</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Axelsson</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Acta Anaesthesiol Scand</MedlineTA>
<NlmUniqueID>0370270</NlmUniqueID>
<ISSNLinking>0001-5172</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000577">Amides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7IO5LYA57N</RegistryNumber>
<NameOfSubstance UI="D000077212">Ropivacaine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>Y8335394RO</RegistryNumber>
<NameOfSubstance UI="D002045">Bupivacaine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000577" MajorTopicYN="N">Amides</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000767" MajorTopicYN="Y">Anesthesia, Epidural</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000779" MajorTopicYN="N">Anesthetics, Local</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002045" MajorTopicYN="N">Bupivacaine</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007268" MajorTopicYN="N">Injections, Epidural</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008465" MajorTopicYN="N">Mechanoreceptors</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009407" MajorTopicYN="N">Nerve Block</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009431" MajorTopicYN="N">Neural Conduction</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009475" MajorTopicYN="N">Neurons, Afferent</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009619" MajorTopicYN="N">Nociceptors</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011187" MajorTopicYN="Y">Posture</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011434" MajorTopicYN="N">Proprioception</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011930" MajorTopicYN="N">Reaction Time</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000077212" MajorTopicYN="N">Ropivacaine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012677" MajorTopicYN="N">Sensation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013823" MajorTopicYN="N">Thermoreceptors</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1996</Year>
<Month>3</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1996</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1996</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">8721466</ArticleId>
<ArticleId IdType="doi">10.1111/j.1399-6576.1996.tb04443.x</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Suède</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Adel, S O" sort="Adel, S O" uniqKey="Adel S" first="S O" last="Adel">S O Adel</name>
<name sortKey="Axelsson, K" sort="Axelsson, K" uniqKey="Axelsson K" first="K" last="Axelsson">K. Axelsson</name>
<name sortKey="Enbom, H" sort="Enbom, H" uniqKey="Enbom H" first="H" last="Enbom">H. Enbom</name>
<name sortKey="Magnusson, M" sort="Magnusson, M" uniqKey="Magnusson M" first="M" last="Magnusson">M. Magnusson</name>
<name sortKey="Nydahl, P A" sort="Nydahl, P A" uniqKey="Nydahl P" first="P A" last="Nydahl">P A Nydahl</name>
<name sortKey="Philipson, L" sort="Philipson, L" uniqKey="Philipson L" first="L" last="Philipson">L. Philipson</name>
</noCountry>
<country name="Suède">
<noRegion>
<name sortKey="Zaric, D" sort="Zaric, D" uniqKey="Zaric D" first="D" last="Zaric">D. Zaric</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PosturoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001503 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001503 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PosturoV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:8721466
   |texte=   The effect of continuous epidural infusion of ropivacaine (0.1%, 0.2% and 0.3%) on nerve conduction velocity and postural control in volunteers.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:8721466" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a PosturoV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Fri Nov 13 22:38:36 2020. Site generation: Thu Mar 25 16:16:50 2021